StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
34
This year
3
Publishing Date
2024 - 03 - 04
1
2024 - 01 - 25
1
2024 - 01 - 08
1
2023 - 12 - 11
1
2023 - 11 - 20
1
2023 - 10 - 30
1
2023 - 05 - 02
1
2023 - 04 - 18
1
2023 - 04 - 13
1
2023 - 04 - 06
1
2023 - 03 - 16
1
2023 - 02 - 27
1
2023 - 02 - 20
1
2023 - 02 - 06
1
2023 - 01 - 30
1
2022 - 12 - 08
1
2022 - 12 - 05
1
2022 - 10 - 27
1
2022 - 10 - 17
1
2022 - 09 - 26
1
2022 - 09 - 19
1
2022 - 08 - 23
1
2022 - 06 - 01
1
2022 - 05 - 18
1
2022 - 03 - 31
1
2022 - 03 - 14
1
2022 - 02 - 18
1
2022 - 02 - 02
1
2022 - 01 - 19
1
2022 - 01 - 04
1
2021 - 12 - 22
1
2021 - 12 - 20
1
2021 - 12 - 02
1
2021 - 10 - 25
1
Sector
Health technology
34
Information
1
Manufacturing
2
N/a
1
Professional, scientific, and technical services
1
Technology services
1
Tags
Acquisition
1
Als
1
Application
2
Authorization
1
Biosimilar
3
Brands
1
Breast
1
Cancer
6
Ces
1
Children
1
Chmp
1
Device
1
Diabetes
1
Disease
1
Ema
1
Europe
2
Expansion
1
Eye
1
Fda
2
Gastrointestinal
1
Gilenya
1
Growing
2
Growth
12
Hypertension
1
Illuccix
1
India
1
Kisqali
1
Leukemia
1
License
1
Liver
1
Lung cancer
1
Market
12
Molecular
1
N/a
34
Nephropathy
1
Novartis
11
Patent
1
Pharma
1
Platform
1
Positive
1
Potential
1
Prostate cancer
1
Qge031
1
Report
1
Research
2
Respiratory
1
Response
1
Results
1
Sabcs
1
Sales
1
Scemblix
1
Study
2
Technology
1
Therapeutics
2
Therapy
3
Topline
1
Treatment
1
Trial
1
Tumors
1
Urticaria
1
Entities
Abbott laboratories
2
Abbvie inc.
5
Acadia pharmaceuticals inc.
1
Aerie pharmaceuticals, inc.
1
Aerovate therapeutics inc
1
Alphabet inc.
1
Amgen inc.
3
Astellas pharma inc
1
Astrazeneca plc
5
Bausch health companies inc.
2
Baxter international inc.
1
Beigene, ltd.
1
Biogen inc.
1
Chinook therapeutics, inc.
1
Clarivate plc
1
Glaxosmithkline plc
7
Jazz pharmaceuticals plc
2
Mallinckrodt plc
1
Medtronic plc
1
Novartis ag
34
Pfizer, inc.
1
Puma biotechnology inc
1
Sanofi
3
Teva pharmaceutical industries ltd
7
Viatris inc.
7
Symbols
AAPL
25
ABB
32
ABBV
25
ABLZF
20
ABT
32
ACN
26
ADBE
21
ALPMF
21
ALPMY
21
ALSMY
41
ALV
19
AOMFF
41
ARVL
120
ASX
27
AVGO
30
BLK
36
BNPQF
208
BNPQY
208
BORR
21
BR
21
CLVT
38
CMCL
54
CYAD
20
EGY
25
EQNR
77
ERIC
56
ESLT
49
FLNG
39
FNCTF
95
GOOG
37
GOOGL
37
HON
40
IDBA
23
IPHA
22
IPHYF
21
JCI
19
JNJ
70
KBCSF
27
KBCSY
27
MDT
27
MS
58
NJDCY
25
NOKBF
20
NVO
36
NVS
39
NVSEF
34
PPRUF
29
PPRUY
29
RYLPF
28
SAP
44
SAPGF
42
SEKEF
20
SEKEY
20
SNY
149
SNYNF
120
STLA
28
STOHF
53
TMO
25
VEON
28
VRNA
30
Exchanges
Nasdaq
34
Nyse
34
Crawled Date
2024 - 03 - 04
1
2024 - 01 - 25
1
2024 - 01 - 08
1
2023 - 12 - 11
1
2023 - 11 - 20
1
2023 - 10 - 30
1
2023 - 05 - 02
1
2023 - 04 - 18
1
2023 - 04 - 13
1
2023 - 04 - 06
1
2023 - 03 - 16
1
2023 - 02 - 27
1
2023 - 02 - 20
1
2023 - 02 - 06
1
2023 - 01 - 30
1
2022 - 12 - 08
1
2022 - 12 - 05
1
2022 - 10 - 27
1
2022 - 10 - 17
1
2022 - 09 - 26
1
2022 - 09 - 19
1
2022 - 08 - 23
1
2022 - 06 - 01
1
2022 - 05 - 18
1
2022 - 03 - 31
1
2022 - 03 - 14
1
2022 - 02 - 18
1
2022 - 02 - 02
1
2022 - 01 - 19
1
2022 - 01 - 04
1
2021 - 12 - 22
1
2021 - 12 - 20
1
2021 - 12 - 02
1
2021 - 10 - 25
1
Crawled Time
00:00
42
00:20
9
01:00
44
02:00
25
03:00
33
04:00
19
04:20
8
05:00
25
06:00
58
07:00
34
08:00
27
08:20
4
09:00
40
10:00
30
11:00
43
11:01
1
12:00
68
12:20
14
12:30
8
13:00
26
13:15
2
13:20
7
13:30
4
14:00
33
14:15
1
14:20
10
14:30
7
14:49
1
15:00
40
15:15
1
15:20
16
15:30
14
16:00
49
16:20
3
17:00
49
18:00
49
19:00
43
20:00
35
20:20
3
21:00
26
22:00
44
23:00
40
Source
www.globenewswire.com
18
www.prnewswire.com
16
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NVSEF
crawled time :
07:00
save search
Novartis presents new data on safety and efficacy of Zolgensma, including maintained and improved motor milestones in older and heavier children with SMA
Published:
2024-03-04
(Crawled : 07:00)
- globenewswire.com
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-3.14%
|
O:
-0.6%
H:
0.68%
C:
0.51%
children
novartis
USD 1.02 billion growth in Gastrointestinal Stromal Tumors Therapeutics (GIST) Market, Increasing awareness campaigns about GIST boosting the growth, 17000 + Technavio
Published:
2024-01-25
(Crawled : 07:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
52K
|
Health Technology
|
-11.93%
|
O:
-3.67%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-8.08%
|
O:
-0.44%
H:
0.19%
C:
-0.08%
tumors
gastrointestinal
therapeutics
growth
Novartis Scemblix® shows superior major molecular response (MMR) rates vs. standard‐of‐care TKIs in Phase III trial for newly diagnosed patients with chronic myeloid leukemia
Published:
2024-01-08
(Crawled : 07:00)
- globenewswire.com
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-7.01%
|
O:
0.89%
H:
0.12%
C:
-0.17%
scemblix
leukemia
trial
response
molecular
Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and statistically significant proteinuria reduction in patients with C3 glomerulopathy (C3G)
Published:
2023-12-11
(Crawled : 07:00)
- globenewswire.com
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
2.66%
|
O:
0.75%
H:
0.55%
C:
0.27%
novartis
study
Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASH
Published:
2023-11-20
(Crawled : 07:00)
- globenewswire.com
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
4.16%
|
O:
-0.18%
H:
0.88%
C:
0.54%
kisqali
sabcs
novartis
Novartis investigational atrasentan Phase III study demonstrates clinically meaningful and highly statistically significant proteinuria reduction in patients with IgA nephropathy (IgAN)
Published:
2023-10-30
(Crawled : 07:00)
- globenewswire.com
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
7.14%
|
O:
1.69%
H:
0.25%
C:
-0.07%
nephropathy
novartis
study
Oncology market size in India to grow by USD 947.84 million between 2022 and 2027; Growth driven by increased prevalence of cancer - Technavio
Published:
2023-05-02
(Crawled : 07:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
1.13%
-4.19%
1.5K
|
Health Technology
|
-4.11%
|
O:
0.33%
H:
0.0%
C:
-0.44%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-3.59%
|
O:
-0.57%
H:
1.69%
C:
1.55%
MDT
|
$81.29
0.89%
-0.11%
4.1M
|
Health Technology
|
-10.36%
|
O:
-0.53%
H:
0.88%
C:
0.03%
BAX
|
$41.02
1.54%
0.8%
2.6M
|
Health Technology
|
-13.42%
|
O:
-0.4%
H:
0.81%
C:
-0.38%
ABT
|
News
|
$107.59
0.49%
0.33%
3.1M
|
Health Technology
|
-3.17%
|
O:
-0.05%
H:
0.79%
C:
0.4%
AZN
|
News
|
$70.85
1.03%
1.02%
4.9M
|
Health Technology
|
-3.61%
|
O:
-0.71%
H:
1.09%
C:
0.99%
GOOGL
|
News
S
|
$158.26
1.27%
1.19%
17M
|
Technology Services
|
46.48%
|
O:
-0.06%
H:
0.06%
C:
-1.7%
GOOG
|
News
4
|
$159.92
1.25%
1.17%
13M
|
Technology Services
|
47.24%
|
O:
-0.05%
H:
0.07%
C:
-1.56%
india
cancer
growth
market
Pulmonary arterial hypertension (PAH) drugs market size to grow by USD 2,080.07 million between 2022 and 2027; Growth driven by growing prevalence of PAH - Technavio
Published:
2023-04-18
(Crawled : 07:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
2.6K
|
Health Technology
|
0.0%
|
O:
-6.76%
H:
3.18%
C:
1.34%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
1.5K
|
Health Technology
|
-4.41%
|
O:
2.33%
H:
0.7%
C:
-0.88%
AVTE
M
|
$23.22
4.74%
4.58%
150K
|
Professional, Scientific, and T...
|
27.93%
|
O:
0.0%
H:
2.26%
C:
1.38%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
3.9M
|
Health Technology
|
14.63%
|
O:
0.2%
H:
0.09%
C:
-0.5%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
0.91%
|
O:
0.18%
H:
0.11%
C:
-0.85%
GSK
|
News
|
$41.24
1.6%
-0.58%
2.1M
|
Health Technology
|
10.3%
|
O:
-0.64%
H:
0.23%
C:
-1.0%
AZN
|
News
|
$70.85
1.03%
1.02%
4.9M
|
Health Technology
|
-3.78%
|
O:
2.35%
H:
0.62%
C:
-0.45%
growing
hypertension
growth
market
BioWorld by Clarivate Explores the New Era of Radiopharmaceuticals and its Emergence as a Novel Cancer Therapy
Published:
2023-04-13
(Crawled : 07:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
52K
|
Health Technology
|
19.63%
|
O:
1.25%
H:
0.51%
C:
0.51%
CLVT
|
$7.14
-0.14%
0.0%
3.2M
|
Information
|
-20.47%
|
O:
0.89%
H:
2.54%
C:
1.87%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
2.48%
|
O:
1.3%
H:
0.56%
C:
0.51%
cancer
therapy
Soft contact lens market size to grow by USD 1.74 billion from 2021 to 2026; Growth driven by rise in the number of people with eye disorders - Technavio
Published:
2023-04-06
(Crawled : 07:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
52K
|
Health Technology
|
21.2%
|
O:
1.0%
H:
0.63%
C:
0.21%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
3.99%
|
O:
1.34%
H:
0.23%
C:
-0.08%
BHC
|
$8.53
0.95%
0.0%
4M
|
Health Technology
|
14.96%
|
O:
0.27%
H:
0.54%
C:
-1.48%
eye
growth
market
FDA Approves Expanded Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Directed Radioligand Therapy
Published:
2023-03-16
(Crawled : 07:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
52K
|
Health Technology
|
42.66%
|
O:
1.16%
H:
0.73%
C:
0.73%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
20.41%
|
O:
0.18%
H:
0.77%
C:
0.64%
illuccix
fda
therapy
Optic Nerve Disorder Treatment Market to Reach USD 5.3 Billion, Globally, by 2031 at 4.5% CAGR: Allied Market Research
Published:
2023-02-27
(Crawled : 07:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.15%
20M
|
Health Technology
|
-36.96%
|
O:
-0.74%
H:
0.7%
C:
-1.59%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
15.46%
|
O:
0.64%
H:
0.01%
C:
-0.72%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
11.02%
|
O:
0.36%
H:
0.97%
C:
0.67%
treatment
research
market
Novartis announces the appointment of the Chairman-Designate of Sandoz Board of Directors
Published:
2023-02-20
(Crawled : 07:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
novartis
Sandoz Biologics License Application for proposed biosimilar denosumab accepted by US FDA
Published:
2023-02-06
(Crawled : 07:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
52K
|
Health Technology
|
34.56%
|
O:
-0.44%
H:
0.0%
C:
-2.93%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
15.15%
|
O:
-0.33%
H:
0.15%
C:
-0.12%
AMGN
|
News
|
$273.54
0.6%
0.65%
1.9M
|
Health Technology
|
11.57%
|
O:
0.08%
H:
0.59%
C:
-0.62%
fda
biosimilar
application
license
Sandoz receives positive CHMP opinion for citrate-free high concentration formulation of adalimumab biosimilar
Published:
2023-01-30
(Crawled : 07:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
52K
|
Health Technology
|
28.0%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
10.47%
|
O:
0.65%
H:
0.37%
C:
-0.48%
biosimilar
chmp
positive
Novartis investigational iptacopan provides clinically meaningful increases in hemoglobin levels in complement-inhibitor-naïve patients with PNH
Published:
2022-12-08
(Crawled : 07:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
52K
|
Health Technology
|
26.59%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
7.77%
|
O:
-1.17%
H:
1.09%
C:
1.01%
novartis
Novartis Pluvicto™ shows statistically significant and clinically meaningful radiographic progression-free survival benefit in patients with PSMA–positive metastatic castration-resistant prostate cancer
Published:
2022-12-05
(Crawled : 07:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
52K
|
Health Technology
|
28.61%
|
O:
0.76%
H:
0.0%
C:
-0.03%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
9.86%
|
O:
0.93%
H:
0.56%
C:
0.14%
novartis
cancer
prostate cancer
Breast Cancer Therapeutics Market Size to Grow by USD 13.85 Bn, Targeted Therapy to be Largest Revenue-generating Product Segment - Technavio
Published:
2022-10-27
(Crawled : 07:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
2.6K
|
Health Technology
|
22.32%
|
O:
0.03%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
1.5K
|
Health Technology
|
22.56%
|
O:
1.47%
H:
0.21%
C:
-0.7%
NVSEF
|
News
|
$96.0
0.94%
6.88%
52K
|
Health Technology
|
49.15%
|
O:
1.09%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
3.9M
|
Health Technology
|
13.94%
|
O:
0.1%
H:
0.85%
C:
-1.1%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
24.18%
|
O:
0.06%
H:
0.44%
C:
-0.15%
GSK
|
News
|
$41.24
1.6%
-0.58%
2.1M
|
Health Technology
|
26.15%
|
O:
-0.12%
H:
0.47%
C:
0.21%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
11.17%
|
O:
0.82%
H:
0.15%
C:
-0.17%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
13.02%
|
O:
0.34%
H:
0.0%
C:
0.0%
PBYI
|
$5.13
-0.77%
-0.98%
290K
|
Health Technology
|
125.0%
|
O:
1.32%
H:
0.43%
C:
-3.46%
AZN
|
News
|
$70.85
1.03%
1.02%
4.9M
|
Health Technology
|
22.24%
|
O:
-0.48%
H:
0.56%
C:
-0.12%
AMGN
|
News
|
$273.54
0.6%
0.65%
1.9M
|
Health Technology
|
2.58%
|
O:
0.5%
H:
0.49%
C:
-0.29%
breast
therapeutics
therapy
cancer
market
Beta-Lactam And Beta-Lactamase Inhibitors Market to grow by USD 9.04 Bn, Pharmaceutical Market to be Parent Market - Technavio
Published:
2022-10-17
(Crawled : 07:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
2.6K
|
Health Technology
|
28.38%
|
O:
0.0%
H:
0.0%
C:
-3.61%
SNYNF
|
News
|
$94.25
1.67%
-2.18%
480
|
Health Technology
|
16.63%
|
O:
0.67%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
3.9M
|
Health Technology
|
18.95%
|
O:
1.05%
H:
0.62%
C:
-0.41%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
30.82%
|
O:
2.36%
H:
0.23%
C:
-0.1%
GSK
|
News
|
$41.24
1.6%
-0.58%
2.1M
|
Health Technology
|
34.29%
|
O:
2.15%
H:
0.67%
C:
-0.22%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
18.61%
|
O:
-0.2%
H:
1.6%
C:
1.23%
ABT
|
News
|
$107.59
0.49%
0.33%
3.1M
|
Health Technology
|
6.62%
|
O:
1.2%
H:
1.79%
C:
1.37%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
17.72%
|
O:
0.51%
H:
0.95%
C:
0.65%
market
Alpha Glucosidase Inhibitors Market to record USD 567.96 Mn incremental growth -- Driven by increase in awareness of diabetes and growing initiatives
Published:
2022-09-26
(Crawled : 07:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
1.67%
-2.18%
480
|
Health Technology
|
28.48%
|
O:
5.77%
H:
0.0%
C:
-2.27%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
1.5K
|
Health Technology
|
29.49%
|
O:
-1.15%
H:
0.0%
C:
-2.43%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
30.06%
|
O:
-2.04%
H:
0.82%
C:
0.2%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
22.62%
|
O:
-2.29%
H:
0.35%
C:
-0.67%
AZN
|
News
|
$70.85
1.03%
1.02%
4.9M
|
Health Technology
|
29.81%
|
O:
-1.52%
H:
0.48%
C:
-1.36%
growing
diabetes
growth
market
← Previous
1
2
Next →
Gainers vs Losers
77%
23%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
26M
|
AGBA
|
$2.97
137.6%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.59
75.27%
41.8%
2M
|
ZAPP
|
$4.44
50.2%
33.12%
370K
|
n/a
MTC
|
$2.24
43.59%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.15
40.0%
29.13%
12M
|
Finance
SHIM
|
$3.045
35.33%
26.23%
870K
|
HKIT
|
$1.33
30.39%
24.16%
390K
|
Technology Services
ABVC
|
$1.35
29.81%
23.53%
7.1M
|
Wholesale Trade
OST
|
$0.5
25.0%
21.88%
280K
|
Your saved searches
Save your searches and get alerts when important news are released.